Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3UL1TR002369-04S2

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2017
    2022
  • Known Financial Commitments (USD)

    $100,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    David H Ellison
  • Research Location

    United States of America
  • Lead Research Institution

    Oregon Health & Science University
  • Research Priority Alignment

    N/A
  • Research Category

    13

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The Oregon Clinical and Translational Research Institute (OCTRI) has been accelerating research at OregonHealth & Science University since 2006. Its many highly functional programs assist investigators and traineesby providing diverse services. Here, we propose that OCTRI will transition to retain our strengths, but alsobecome a key hub in the national network, by focusing on five crosscutting aims. These align closely with thegoals of the Funding Opportunity Announcement, and the goals outlined by NCATS for the CTSA program inan ideal state. OCTRI's overall aims are to:Overall Aim 1: Catalyze Clinical and Translational Research.Overall Aim 2: Enhance Partnerships with Communities.Overall Aim 3: Foster and Support Scientific Collaboration.Overall Aim 4: Expand the Translational Workforce for the 21st Century.Overall Aim 5: Cultivate Innovation in Research.We have organized a highly functional leadership structure to enable us to meet these goals, and will seek theguidance of several advisory groups. We will catalyze research by developing and supporting new informaticsapproaches that both integrate the clinical care enterprise with the research enterprise and facilitate therecruitment of patients into clinical trials, locally and across the CTSA network. We will engage diversestakeholders in the translational research process, by partnering with OHSU investigators, communitycoalitions, and business enterprises. We will foster team science through local awards to trainees and toemerging investigators. We will partner with regional institutions to foster community-engaged research, toenhance the diversity of trainees, and to provide opportunities in biomedical research not available at otherinstitutions. We will train clinical and translational scientists and research staff for the next generation, byfocusing on the skills and attitudes necessary for research in the future. At all steps, we will measure outcomesand, when necessary, "turn the curve."